Hypertension Guidance Calculator
Classify blood pressure per the 2017 ACC/AHA guideline and get treatment guidance: normal, elevated, stage 1 and stage 2 thresholds with lifestyle and medication recommendations.
Enter systolic and diastolic pressure plus key risk context to get the ACC/AHA blood pressure category and guideline-based guidance on lifestyle therapy and medication thresholds. Confirm the classification with proper measurement technique and out-of-office readings where indicated.
What changed in the 2017 guideline
The 2017 American College of Cardiology and American Heart Association guideline redefined hypertension downward: 130 over 80 mm Hg became the diagnostic threshold, replacing the 140 over 90 cut-off used for decades. The change was driven by accumulating evidence that cardiovascular risk rises continuously from blood pressures well below the old threshold, and by the SPRINT trial, which showed that targeting a systolic pressure under 120 mm Hg reduced events compared with targeting under 140 in high-risk patients. Overnight, millions of people with pressures of 130 to 139 over 80 to 89 moved from prehypertension into stage 1 hypertension.
Crucially, the new label did not mean new drugs for everyone. The guideline deliberately separated diagnosis from drug therapy: stage 1 hypertension triggers medication only in patients with established cardiovascular disease or a 10-year ASCVD risk of at least 10 percent, while lower-risk stage 1 patients start with lifestyle therapy and reassessment. The redefinition was about earlier attention, not automatic prescriptions, and understanding that distinction is the key to using the categories well.
The four categories
Normal blood pressure, under 120 over under 80, calls for healthy lifestyle habits and rechecking within a year, because risk is relative and pressures drift upward with age. Elevated blood pressure, systolic 120 to 129 with diastolic under 80, is the warning zone: no drugs, but active lifestyle intervention and rechecking in 3 to 6 months, since a substantial fraction of these patients progress to hypertension. Note the diastolic condition: 120 to 129 systolic with a diastolic of 80 or above is stage 1, not elevated.
Stage 1 hypertension, 130 to 139 systolic or 80 to 89 diastolic, is the decision zone. With high cardiovascular risk, diabetes, chronic kidney disease or established vascular disease, medication starts alongside lifestyle measures. Without those, lifestyle therapy leads and pressure is rechecked in 3 to 6 months, with medication added if control is not achieved. Stage 2 hypertension, 140 or above systolic or 90 or above diastolic, warrants both lifestyle measures and blood pressure lowering medication from the outset, with prompt follow-up and usually two first-line agents when pressure exceeds target by more than 20 over 10.
Treatment thresholds and targets
The medication threshold and the treatment target are different numbers and should not be confused. Thresholds decide whether to start drugs: 130 over 80 for high-risk stage 1 patients and for all stage 2 patients. The target decides how far to go once treatment starts: under 130 over under 80 for most treated adults. For patients already on therapy whose pressure sits above target, the guidance is to intensify, not to accept, the current regimen, provided the patient tolerates it.
First-line agents are thiazide or thiazide-like diuretics, ACE inhibitors, angiotensin receptor blockers and calcium channel blockers, chosen according to comorbidities: ACE inhibitors or ARBs for diabetes with albuminuria or heart failure with reduced ejection fraction, for example. Most patients with stage 2 hypertension need two agents from different classes to reach target, and single-pill combinations improve adherence. Follow-up should be monthly until control is achieved, then every 3 to 6 months.
Lifestyle therapy: the foundation for every category
Lifestyle measures are recommended at every blood pressure level, including normal, and their effects are additive. Weight loss lowers systolic pressure roughly 1 mm Hg per kilogram lost. The DASH dietary pattern, rich in fruits, vegetables and low-fat dairy, lowers systolic pressure by about 11 mm Hg in hypertensive patients. Sodium reduction toward 1,500 mg daily, potassium supplementation through diet, at least 150 minutes of aerobic activity weekly, and limiting alcohol to moderate levels each contribute several mm Hg. Together these measures can match a drug, which is why the guideline treats them as therapy rather than advice.
Measurement and confirmation
Classification is only as good as measurement. Proper technique means seated with back supported and feet flat, arm supported at heart level, correct cuff size, 5 minutes of rest, no talking, and no caffeine, exercise or smoking for 30 minutes beforehand. Diagnosis should rest on the average of readings across at least two visits, and out-of-office measurement is recommended to confirm: home monitoring with a validated device, or 24-hour ambulatory monitoring, which additionally reveals nocturnal non-dipping, a potent risk marker. White-coat hypertension needs lifestyle therapy and surveillance rather than drugs; masked hypertension carries real risk and needs treatment.
Limitations
The 2017 thresholds come from an American guideline; European guidance retains 140 over 90 as the office diagnostic threshold, so the same patient can be hypertensive in one system and not in the other. The categories apply to office measurements; home and ambulatory thresholds are lower. Very elderly or frail patients need individualised targets because intensive lowering can cause hypotension, falls and renal injury. Secondary hypertension, suspected from young onset, resistant hypertension, or suggestive features, needs dedicated workup rather than classification alone. Finally, this tool classifies and advises; it does not diagnose, and the diagnosis of hypertension properly requires repeated properly measured readings over time.
References
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension. 2018;71(6):e13-e115.
- SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103-2116.
- Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104.
Key takeaways
- ACC/AHA categories are normal (under 120/80), elevated (120 to 129 systolic with diastolic under 80), stage 1 (130 to 139 or 80 to 89), and stage 2 (140 or higher or 90 or higher).
- Hypertension is diagnosed at 130 over 80, but medication in stage 1 starts only with high cardiovascular risk, diabetes, CKD or established vascular disease.
- Stage 2 hypertension generally needs medication plus lifestyle therapy from the outset, often two agents.
- The treatment target for most treated adults is under 130 over under 80.
- Lifestyle measures, weight, DASH diet, sodium reduction, exercise and alcohol limits, are therapy at every category and their effects add up.
- Confirm the diagnosis with proper technique and out-of-office measurement to exclude white-coat and masked hypertension.
Frequently asked questions
What are the blood pressure categories in the 2017 ACC/AHA guideline?
Normal is under 120 over under 80 mm Hg. Elevated is systolic 120 to 129 with diastolic under 80. Stage 1 hypertension is systolic 130 to 139 or diastolic 80 to 89. Stage 2 hypertension is systolic 140 or higher or diastolic 90 or higher. The higher of the systolic or diastolic category determines the classification.
When does stage 1 hypertension need medication?
In stage 1 hypertension, the 2017 ACC/AHA guideline recommends blood pressure lowering medication for patients with established cardiovascular disease or a 10-year ASCVD risk of 10 percent or higher, and lifestyle therapy with re-evaluation for lower-risk patients. Medication is generally recommended for all stage 2 hypertension alongside lifestyle measures.
What is the blood pressure target?
The 2017 ACC/AHA guideline sets a general treatment target of under 130 over under 80 mm Hg for most treated adults, including those with cardiovascular disease, diabetes, and chronic kidney disease. Targets should be individualised for frail older adults and those at risk of adverse effects from intensive lowering.
What lifestyle measures lower blood pressure?
The guideline emphasises weight loss where overweight, a heart-healthy dietary pattern such as DASH, sodium reduction, potassium supplementation preferably through diet, regular aerobic physical activity, and limiting alcohol. Each measure lowers systolic pressure by several mm Hg, and their effects add up, so lifestyle therapy is recommended for every blood pressure category including normal.
How should blood pressure be measured for classification?
Classification should rest on properly measured office readings: seated after 5 minutes rest, back supported, feet flat, arm supported at heart level, correct cuff size, no talking, and no caffeine, exercise or smoking in the prior 30 minutes. The average of two or more readings on two or more occasions confirms the diagnosis, and out-of-office measurement with home or ambulatory monitoring is recommended to exclude white-coat and masked hypertension.
Why do American and European thresholds differ?
The 2017 ACC/AHA guideline set the office diagnostic threshold at 130 over 80 based largely on SPRINT and meta-analytic evidence, while the 2018 ESC/ESH guideline retained 140 over 90, judging the evidence for drug benefit below that level insufficient. Both agree on out-of-office thresholds and on intensive treatment of high-risk patients; the practical difference mainly affects labelling of stage 1 patients.